These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25684406)

  • 1. Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking.
    García-Pérez E; Mahfooz K; Covita J; Zandueta A; Wesseling JF
    Epilepsia; 2015 Apr; 56(4):535-45. PubMed ID: 25684406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brivaracetam augments short-term depression and slows vesicle recycling.
    Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM
    Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.
    Meehan AL; Yang X; McAdams BD; Yuan L; Rothman SM
    J Neurophysiol; 2011 Sep; 106(3):1227-39. PubMed ID: 21653714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.
    Boido D; Farisello P; Cesca F; Ferrea E; Valtorta F; Benfenati F; Baldelli P
    Neuroscience; 2010 Nov; 171(1):268-83. PubMed ID: 20804820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.
    Yang XF; Weisenfeld A; Rothman SM
    Epilepsia; 2007 Oct; 48(10):1861-9. PubMed ID: 17521346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam has an activity-dependent effect on inhibitory transmission.
    Meehan AL; Yang X; Yuan LL; Rothman SM
    Epilepsia; 2012 Mar; 53(3):469-76. PubMed ID: 22292611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synapsin-dependent development of glutamatergic synaptic vesicles and presynaptic plasticity in postnatal mouse brain.
    Bogen IL; Jensen V; Hvalby O; Walaas SI
    Neuroscience; 2009 Jan; 158(1):231-41. PubMed ID: 18606212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway.
    Vogl C; Mochida S; Wolff C; Whalley BJ; Stephens GJ
    Mol Pharmacol; 2012 Aug; 82(2):199-208. PubMed ID: 22554805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam resistance: Synaptic signatures & corresponding promoter SNPs in epileptic hippocampi.
    Grimminger T; Pernhorst K; Surges R; Niehusmann P; Priebe L; von Lehe M; Hoffmann P; Cichon S; Schoch S; Becker AJ
    Neurobiol Dis; 2013 Dec; 60():115-25. PubMed ID: 24018139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seletracetam enhances short term depression in vitro.
    Yang X; Meehan AL; Rothman SM; Dubinsky JM
    Epilepsy Res; 2015 Nov; 117():17-22. PubMed ID: 26320080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action.
    Nicolas JM; Hannestad J; Holden D; Kervyn S; Nabulsi N; Tytgat D; Huang Y; Chanteux H; Staelens L; Matagne A; Mathy FX; Mercier J; Stockis A; Carson RE; Klitgaard H
    Epilepsia; 2016 Feb; 57(2):201-9. PubMed ID: 26663401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synapsin-dependent reserve pool of synaptic vesicles supports replenishment of the readily releasable pool under intense synaptic transmission.
    Vasileva M; Horstmann H; Geumann C; Gitler D; Kuner T
    Eur J Neurosci; 2012 Oct; 36(8):3005-20. PubMed ID: 22805168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD; Gillard M
    Epilepsia; 2017 Feb; 58(2):255-262. PubMed ID: 28012162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam.
    Krishna K; Raut AL; Gohel KH; Dave P
    J Assoc Physicians India; 2011 Oct; 59():656-8. PubMed ID: 22479748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Ca(2+)-regulated exocytosis by levetiracetam, a ligand for SV2A, in antral mucous cells of guinea pigs.
    Harada S; Tanaka S; Takahashi Y; Matsumura H; Shimamoto C; Nakano T; Kuwabara H; Sawabe Y; Nakahari T
    Eur J Pharmacol; 2013 Dec; 721(1-3):185-92. PubMed ID: 24076180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
    Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
    Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam inhibits endocytosis and augments short-term depression.
    Pharmazie; 2018 Nov; 73(11):643-646. PubMed ID: 30396382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synapsin dispersion and reclustering during synaptic activity.
    Chi P; Greengard P; Ryan TA
    Nat Neurosci; 2001 Dec; 4(12):1187-93. PubMed ID: 11685225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
    van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
    Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.